World, Europe

EU drug regulator meets to discuss AstraZeneca vaccine

Meeting comes after several European countries suspend use of COVID-19 vaccine developed by Oxford/AstraZeneca

Omer Tugrul Cam   | 15.03.2021
EU drug regulator meets to discuss AstraZeneca vaccine


The European Medicine Agency (EMA) convened on Monday to discuss possible side effects of the COVID-19 vaccine developed by Oxford/AstraZeneca.

According to Belgian media, EMA is expected to made a statement on the safety of the vaccine following the meeting or on Thursday.

European countries, including Germany, France, Italy, Ireland, the Netherlands, Denmark and Norway, have suspended the use of AstraZeneca in recent weeks, after reports of people developing blood clots after receiving the jab.

AstraZeneca’s coronavirus vaccine is used to prevent the COVID-19 infection in people aged 18 years and above. It has been designed to prepare the immune system to identify and combat the coronavirus SARS-CoV-2 causing COVID-19.

Anadolu Agency website contains only a portion of the news stories offered to subscribers in the AA News Broadcasting System (HAS), and in summarized form. Please contact us for subscription options.
Related topics
Bu haberi paylaşın